Assura Plc (LON:AGR - Get Free Report) insider Jayne Cottam bought 363 shares of the stock in a transaction on Wednesday, March 5th. The shares were acquired at an average cost of GBX 41 ($0.53) per share, for a total transaction of £148.83 ($191.62).
Jayne Cottam also recently made the following trade(s):
- On Wednesday, February 5th, Jayne Cottam bought 405 shares of Assura stock. The shares were acquired at an average cost of GBX 37 ($0.48) per share, for a total transaction of £149.85 ($192.93).
Assura Stock Up 14.3 %
Assura stock traded up GBX 5.82 ($0.07) during mid-day trading on Monday, hitting GBX 46.56 ($0.60). 78,156,086 shares of the company's stock were exchanged, compared to its average volume of 21,937,410. The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05. The stock has a market cap of £1.52 billion, a P/E ratio of -44.51, a P/E/G ratio of 3.60 and a beta of 0.37. Assura Plc has a 1-year low of GBX 35.24 ($0.45) and a 1-year high of GBX 46.86 ($0.60). The stock has a 50 day moving average of GBX 38.87 and a two-hundred day moving average of GBX 39.81.
Assura Company Profile
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Further Reading

Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.